Authors: Demarquay, D Huchet, M Coulomb, H Lesueur-Ginot, L Lavergne, O Kasprzyk, PG Bailly, C Camara, J Bigg, DCH

Citation: D. Demarquay et al., The homocamptothecin BN 80915 is a highly potent orally active topoisomerase I poison, ANTI-CANC D, 12(1), 2001, pp. 9-19

Authors: Papadopoulos, V Kapsis, A Li, H Amri, H Hardwick, M Culty, M Kasprzyk, PG Carlson, M Moreau, JP Drieu, K

Citation: V. Papadopoulos et al., Drug-induced inhibition of the peripheral-type benzodiazepine receptor expression and cell proliferation in human breast cancer cells, ANTICANC R, 20(5A), 2000, pp. 2835-2847

Authors: Lesueur-Ginot, L Demarquay, D Kiss, R Kasprzyk, PG Dassonneville, L Bailly, C Camara, J Lavergne, O Bigg, DCH

Citation: L. Lesueur-ginot et al., Homocamptothecin, an E-ring modified camptothecin with enhanced lactone stability, retains topoisomerase I-targeted activity and antitumor properties, CANCER RES, 59(12), 1999, pp. 2939-2943

Authors: Lavergne, O Lesueur-Ginot, L Rodas, FP Kasprzyk, PG Pommier, J Demarquay, D Prevost, G Ulibarri, G Rolland, A Schiano-Liberatore, AM Harnett, J Pons, D Camara, J Bigg, DCH

Citation: O. Lavergne et al., Homocamptothecins: Synthesis and antitumor activity of novel E-ring-modified camptothecin analogues, J MED CHEM, 41(27), 1998, pp. 5410-5419